Doctor Ali Mroueh
Strasbourg (France)
Follow
Contributor content
Presentation
Combined SGLT2 inhibition and GLP-1 receptor agonism synergistically reduce rejection-associated oxidative stress in cardiac allografts of heart transplant recipients
Presentation
Gliflozin therapy attenuates persistent systemic inflammation and monocyte metabolic dysfunction post-ACS: a comparative study across the CAD spectrum
Presentation
Inflammation promotes extra-adrenal-ang II–independent aldosterone release by circulating immune cells in patients with coronary artery disease
Presentation
Gliflozin therapy is associated with reduced monocyte activation and plasma-induced oxidative stress in endothelial cells and cardiomyocytes of patients with hypertrophic cardiomyopathy.
Presentation
Monocytes from CAD patients displayed M1 phenotype and released inflammatory mediators inducing endothelial dysfunction: M1 resolution and endothelial protection by SGLT2i + GLP-1Ra synergism
Presentation
Plasma from endometriosis patients and endometriosis tissue-derived pro-inflammatory cytokines promote endothelial dysfunction through activation of the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
Presentation
SGLT2 expression in the left ventricle of cardiac patients is correlated with low-grade inflammation involving the pro-oxidant AT1R/NADPH oxidases/SGLT2 crosstalk: potential role in heart failure
Presentation
SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: Potential protective effect of SGLT2 inhibitors
Presentation
